BACKGROUND To ascertain whether findings from hospital based clinical series can be
extended to patients with idiopathic pulmonary fibrosis (IPF) in the general population, the …

Idiopathic pulmonary fibrosis (IPF) is a rare disease, with estimates of prevalence varying
considerably across countries due to paucity in data collection. The aim of this study was to …

Background Limited data exist regarding the population-based epidemiology of idiopathic
pulmonary fibrosis (IPF). The objective of the study was to describe the trends in the …

BACKGROUND: This study took advantage of a large population-based database of the
Taiwan National Health Insurance (NHI) to investigate the epidemiology of idiopathic …

Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established
to better understand its natural history, though their size and duration of follow-up are …

Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …

Results A total of 82,702 deaths were attributed to IPF-CS in England and Wales from 1979
to 2016. The overall age-standardized mortality rate for this period was 4.68 per 100,000 …

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a common subtype of interstitial lung
disease (ILD). Information about the associated comorbidities and predictors of survival …

Introduction Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized
include changes in vital capacity and radiologic findings. However, most of the prognostic …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease
characterised by progressive loss of lung function. Its clinical course is variable but …